NovoNorm | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

NovoNorm
EDQM

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

pharmacompass-1-m-2026-04-20

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

pharmacompass-2-m-2026-04-20

NovoNorm

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 12 USDMF, 11 CEP/COS, 3 JDMF, 8 EU WC, 2 KDMF, 8 NDC API, 18 Listed Suppliers

30 API Suppliers
12 USDMF
11 CEP/COS
3 JDMF
8 EU WC
2 KDMF
8 NDC API
18 Listed Suppliers

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

368 FDF Dossiers, 31 FDA Orange Book, 291 Europe, 15 Canada, 6 South Africa, 25 Listed Dossiers

368 FDF Dossiers
31 FDA Orange Book
291 Europe
15 Canada
6 South Africa
25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG;1MG, TABLET;ORAL - 500MG;2MG

TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG;1MG
TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 6 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 5 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 27 BASF, 1 Corel Pharma Chem, 3 DFE Pharma, 1 Doshion Polyscience, 2 Esteem Industries, 2 Finar, 9 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 1 JJ Chemicals, 1 Kerry, 2 Keval Exports, 8 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 25 Roquette, 1 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders, 22 Direct Compression, 21 Solubilizers, 21 Thickeners and Stabilizers, 20 Granulation, 19 Disintegrants & Superdisintegrants, 17 Topical, 16 Lubricants & Glidants, 16 Film Formers & Plasticizers, 15 Taste Masking, 14 Co-Processed Excipients, 12 Controlled & Modified Release, 11 Coating Systems & Additives, 11 Parenteral, 9 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 3 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 Soft Gelatin

49 Fillers, Diluents & Binders
22 Direct Compression
21 Solubilizers
21 Thickeners and Stabilizers
20 Granulation
19 Disintegrants & Superdisintegrants
17 Topical
16 Lubricants & Glidants
16 Film Formers & Plasticizers
15 Taste Masking
14 Co-Processed Excipients
12 Controlled & Modified Release
11 Coating Systems & Additives
11 Parenteral
9 Chewable & Orodispersible Aids
6 Emulsifying Agents
3 API Stability Enhancers
2 Surfactant & Foaming Agents
2 Rheology Modifiers
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 8 News #PharmaBuzz

1 Data Compilation #PharmaFlow
8 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 88 Regulatory FDF Prices, 5 Annual Reports

4 US Medicaid Prescriptions
88 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

7 APIs, 2 FDF Dossiers

7 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 6 Others

3 EDQM
6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1Y0000457

02 1Y0000458

03 1Y0000459

filter CAS Number Reset all filters

3 All

01 2135062-02-1

02 1147770-08-9

filter Reference Standard Reset all filters

3 All

01 1Repaglinide

02 1Repaglinide for system suitability

03 1Repaglinide impurity E

Product Main Page

01

EDQM, Council of Europe

Repaglinide for system suitability

German Wound Congress

Not Confirmed

01

EDQM, Council of Europe

German Wound Congress

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide for system suitability

CAS Number : 135062-02-1

Quantity Per Vial : 6 mg

Sale Unit : 1

Order Code : Y0000458

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Repaglinide impurity E

German Wound Congress

Not Confirmed

02

EDQM, Council of Europe

German Wound Congress

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide impurity E

CAS Number : 147770-08-9

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0000459

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Repaglinide

German Wound Congress

Not Confirmed

03

EDQM, Council of Europe

German Wound Congress

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide

CAS Number : 135062-02-1

Quantity Per Vial : 20 mg

Sale Unit : 1

Order Code : Y0000457

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.